Key facts
- It has raised $14.1M.
- Notable investors include Besadno Group, Daniel Naor, Horizon 2020, Israel Makov, Merchavia Holdings And Investments — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for CardiacSense
- ·The full record, as it builds
Funding rounds
No funding rounds for CardiacSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CardiacSense
Developer of a medical wearable device designed for monitoring heart arrhythmias. The company's device leverages PPG technology to track electrocardiogram readings and adverse blood pressure with a focus on atrial fibrillation and cardiac arrest, enabling the healthcare industry to measure cardiac attacks and take relevant precautions before any serious occurrence.
- Sector
- Healthcare
- HQ
- Caesarea, Israel
- Founded
- 2009
- Employees
- 27
- Website
- cardiacsense.com/
- Ownership
- Privately Held (backing)
CardiacSense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CardiacSense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CardiacSense in its N-PORT filings yet. We sweep new filings monthly.